Vyaire Medical competitors

Dr. Singh was elected President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and appointed to our board of directors in August 2019. Previously Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals. Dr. Singh has more than twenty-five years of leadership experience with global innovators in healthcare technology. He has spent the most recent six years developing unique insights into both our business and our opportunities for continued growth. Dr. Singh brings to our board a detailed understanding of the core technologies that we utilize and the operational strategies available to us as we continue to focus on innovating for a healthier world.

Founder of The Chopra Foundation, a non-profit entity for research on well-being and humanitarianism, and Chopra Global, a whole health company at the intersection of science and spirituality, is a world-renowned pioneer in integrative medicine and personal transformation. Chopra is a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego and serves as a senior scientist with Gallup Organization.

Gary Burbach is a Chief Executive Officer at Thoratec and is based in Pleasanton, California.

John Goehrke is a Board Member at Laird Durham Inc and Chief Executive Officer at HexaTech Inc and is based in Cary, North Carolina. He has worked as Chief Executive Officer at Nextreme Thermal Solutions, Chief Executive Officer at Luna Innovations, and Chief Executive Officer at Centice. John studied at UNIVERSITY OF CONNECTICUT between 1975 and 1980, University of Pittsburgh - PITT, and Katz Graduate School of Business between 1982 and 1983.

Scott Hirsch is a Chief Executive Officer at SOLTA MEDICAL INC and is based in New York City, New York. He has worked as Lead Equity Research Analyst, Specialty Pharmaceuticals and Global Generics at Credit Suisse Group AG and Vice President, Portfolio Manager at Plural Investments,LLC. Scott A. works or has worked as Portfolio Manager at Citadel. He studied at The Wharton School between 2004 and 2006 and Rhode Island School of Design.